Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytokinetics

45.43
+2.335.41%
Post-market: 45.750.3200+0.70%19:05 EDT
Volume:3.73M
Turnover:170.00M
Market Cap:5.38B
PE:-8.63
High:47.00
Open:42.72
Low:42.70
Close:43.10
Loading ...

Cytokinetics assumed with an Overweight at Morgan Stanley

TIPRANKS
·
07 Mar

Cytokinetics (CYTK) Receives a New Rating from Morgan Stanley

TIPRANKS
·
07 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: AnaptysBio (ANAB), Cytokinetics (CYTK) and uniQure (QURE)

TIPRANKS
·
06 Mar

B.Riley Financial Reaffirms Their Buy Rating on Cytokinetics (CYTK)

TIPRANKS
·
05 Mar

Revenue Downgrade: Here's What Analysts Forecast For Cytokinetics, Incorporated (NASDAQ:CYTK)

Simply Wall St.
·
05 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Owens & Minor (OMI), Acadia Healthcare (ACHC) and Cytokinetics (CYTK)

TIPRANKS
·
05 Mar

Cytokinetics to Participate in March Investor Conferences

GlobeNewswire
·
04 Mar

Cytokinetics Positioned for Growth with Aficamten’s Imminent Launch and Strong Financials

TIPRANKS
·
03 Mar

Cytokinetics (CYTK) Gets a Buy from Truist Financial

TIPRANKS
·
03 Mar

Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Warby Parker (WRBY) and 89bio (ETNB)

TIPRANKS
·
03 Mar

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), DENTSPLY SIRONA (XRAY) and Cytokinetics (CYTK)

TIPRANKS
·
03 Mar

Cytokinetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
01 Mar

Cytokinetics’ Earnings Call: Progress Amid Challenges

TIPRANKS
·
01 Mar

Cytokinetics Q4 Loss Wider Than Expected, Aficamten in Focus

Zacks
·
01 Mar

Q4 2024 Cytokinetics Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Mar

Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb